logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Mathilde Jalving

university medical center groningen
H指数:30
被引数:4,103

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)

黑色素瘤新辅助治疗的五年生存率：国际黑色素瘤新辅助治疗协作组（INMC）更新的汇总分析

Nature Medicine
IF50
2026-10-010
OAAI
Georgina V. Long; Inês Pires da Silva; Kristen A. Perry; Jurriaan Romano; Serigne N. Lo; Piyush Grover; Paolo A. Ascierto; Rodabe N. Amaria; Tina J. Hieken; Caroline Robert; Lucie Heinzerling; Shahneen Sandhu; Milton Barros; Tara C. Mitchell; Zeynep Eroglu; Igor V. Samoylenko; Lukas Flatz; Céleste Lebbé; Douglas B. Johnson; Piotr Rutkowski; Eva Muñoz-Couselo; Omid Hamid; Claudia Trojaniello; Domenico Mallardo; Matthew S. Block; Naima Hammoudi; Naima Benannoune; Dirk Tomsitz; Yang Wang; Cigdem Dinckal; Angelina Kuzmenko; Andrea Forschner; Matteo S. Carlino; Mathilde Jalving; Michael A. Postow; P. Francesco Ferrucci; Ellen Kapiteijn; Astrid A. M. van der Veldt; Karijn P. M. Suijkerbuijk; Laetitia da Meda; Hannah Burnette; Anna Czarnekca; Inderjit Mehmi; Geke Hospers; Sarah Lochrin; Alexander C. J. van Akkooi; Hussein A. Tawbi; Elizabeth M. Burton; Michael T. Tetzlaff; Bart A. van de Wiel; Robert V. Rawson; Christian U. Blank; Alexander M. Menzies
Towards appropriate guidance for the ethical challenges of environmentally sustainable prescribing

面向环境可持续处方中伦理挑战的适当指导

British Journal of Clinical Pharmacology
IF3
2026-09-180
OAAI
Joost D. Piët; Steven R. Kraaijeveld; Erik M. Donker; Milan C. Richir; Caroline T. A. Moermond; Amy Booth; SanYuMay Tun; Thijs H. Oude Munnink; Patricia M. L. A. van den Bemt; Lorena Dima; Ben J. A. Janssen; Mathilde Jalving; Tomás Mauro van Emden; Fabrizio de Ponti; Robert Likic; João Costa; Marc Labriffe; Charlotte L. Bekker; Carlotta Lunghi; Elisabetta Poluzzi; Michiel A. van Agtmael; Yolande Voskes; Jelle Tichelaar
Programmed death ligand 1 (PD-L1) PET/CT imaging to evaluate tumour saturation during atezolizumab treatment

程序性死亡配体1（PD-L1）PET/CT成像评估阿特珠治疗期间肿瘤饱和度

British Journal of Cancer
IF6.8
2026-09-100
OAAI
Jahlisa S. Hooiveld-Noeken; Pim P. van de Donk; Laura Kist de Ruijter; Iris C. Kok; Claudia A. J. van Winkel; Danique Giesen; Marjolijn N. Lub-de Hooge; Adrienne H. Brouwers; Sjoukje F. Oosting; Frederike Bensch; Lotte M. Smit; Carolien P. Schröder; Mathilde Jalving; Sjoerd G. Elias; Jourik A. Gietema; Regula J. Deurloo; Simon P. Williams; Alexander Ungewickell; Derk-Jan A. de Groot; Elisabeth G. E. de Vries
primary analysis of the RANDOMIZED eortc-2139/columbus-ad trial: Adjuvant encorafenib and binimetinib versus placebo in high-risk stage II BRAF-V600E/K melanoma

随机化EORTC-2139/COLUMBUS-AD试验的初步分析：辅助恩考拉芬尼和比尼替尼与安慰剂在高风险II期BRAF-V600E/K黑色素瘤中的比较

European Journal of Cancer
IF7.1
2026-07-210
PRE
Alexander CJ van Akkooi; Michal Kicinski; Anne-Sophie Govaerts; Axel Hauschild; Piotr Rutkowski; Petr Arenberger; Paolo A. Ascierto; Piotr Tomczak; Gaëlle Quereux; Federica De Galitiis; Caroline Dutriaux; Christoffer Gebhardt; Ellen Kapiteijn; Laurent Machet; Miguel GA Berciano; Michele Del Vecchio; Mathilde Jalving; Thomas Jouary; Ivana Krajsova; Suzana Matkovic
Translating ctDNA into cutaneous melanoma care: an international expert survey

将ctDNA应用于皮肤黑色素瘤护理：一项国际专家调查

European Journal of Cancer
IF7.1
2026-03-190
PRE
Glenn Geidel; Nathan Fekade; Katharina Raabe; Daniel J. Smit; Laura Adam; Isabel Heidrich; Alessandra Rünger; Julian Kött; Tim Zell; Teresa Amaral; Paolo A. Ascierto; Pippa Corrie; Reinhard Dummer; Alexander Eggermont; Jun Guo; Jessica C. Hassel; Mathilde Jalving; Douglas B. Johnson; Lidija Kandolf; John M. Kirkwood
Correction: Govaerts et al. Incidence and Clinical Features of Pseudoprogression in Brain Metastases After Immune-Checkpoint Inhibitor Therapy: A Retrospective Study. Cancers 2025, 17, 2425

更正：Govaerts et al. 免疫检查点抑制剂治疗后脑转移瘤中假性进展的发生率及临床特征：一项回顾性研究。Cancers 2025, 17, 2425

Cancers
IF4.4
2026-02-100
OAAI
Chris W. Govaerts; Miranda C. A. Kramer; Ingeborg Bosma; Frank A. E. Kruyt; Frederike Bensch; J. Marc C. van Dijk; Mathilde Jalving; Anouk van der Hoorn
Longitudinal data on advanced cutaneous squamous cell carcinoma from the Dutch Keratinocyte Cancer Collaborative (DKCC): a nationwide real-world database study

荷兰角蛋白细胞癌协作组（DKCC）关于晚期皮肤鳞状细胞癌的纵向数据：一项全国性真实世界数据库研究

The Lancet Regional Health - Europe
IF0
2025-10-180
OAAI
Loes M. Hollestein; Celeste J. Eggermont; Marieke W.J. Louwman; Kay Schreuder; Meggie C.M. Drissen; Olivia F.M. Steijlen; Antien L. Mooyaart; Annette H. Bruggink; Quirinus J.M. Voorham; Dirk J. Grunhagen; Mathilde Jalving; Tamar E.C. Nijsten; Marlies Wakkee
Molecular Tumor Board of the University Medical Center Groningen (UMCGMTB): outcome of patients with rare or complex mutational profiles receiving MTB-advised targeted therapy

格罗宁根大学医学中心 (UMCGMTB) 的分子肿瘤委员会: 接受MTB建议的靶向治疗的罕见或复杂突变特征的患者的结果

ESMO OPEN
IF8.3
2024-11-010
OAAI
deJager, V. D.; Plomp, P.; Paats, M. S.; van Helvert, S.; ter Elst, A.; van den Berg, A.; Dubbink, H. J.; van Geffen, W. H.; Zhang, L.; Hendriks, L. E. L.; Hiltermann, T. J. N.; Hiddinga, B. I.; Hijmering-Kappelle, L. B. M.; Jalving, M.; Kluiver, J.; Koopman, B.; van Kruchten, M.; van der Logt, E. M. J.; Piet, B.; van Putten, J.; Reitsma, B. H.; Rutgers, S. R.; de Vries, M.; Stigt, J. A.; Groves, M. R.; Timens, W.; Willems, S. M.; van Kempent, L. C.; Schuuring, E.; van der Wekken, A. J.
Environmentally sustainable prescribing: recommendations for EU pharmaceutical legislation
LANCET PLANETARY HEALTH
IF21.6
2024-10-013
OAAI
Piet, Joost; Booth, Amy; Donker, Erik M.; de Ponti, Fabrizio; Lunghi, Carlotta; Poluzzi, Elisabetta; Janssen, Ben J. A.; Tun, SanyuMay; Bekker, Charlotte; Dima, Lorena; Costa, Joao; Jalving, Mathilde; Munnink, Thijs H. Oude; van den Bemt, Patricia M. L. A.; Labriffe, Marc; van Emden, Tomas; van Waardenburg, Vera; Likic, Robert; Richir, Milan; van Agtmael, Michiel A.; Moermond, Caroline T. A.; Tichelaar, Jelle
Debio 0123+carboplatin (CP) for patients (pts) with advanced solid tumors: Safety, preliminary efficacy and determination of recommended phase II dose (RP2D)

Debio 0123+顺铂（CP）用于晚期实体瘤患者的治疗：安全性、初步疗效及推荐II期剂量的确定（RP2D）

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Gelderblom, H.; Gadea, O. Saavedra Santa; Jalving, M.; Desar, I.; Gietema, J. A.; Oberoi, A.; Van Herpen, C.; Kroep, J. R.; Franzen, R. Frederiksen; Bellon, A.; Micallef, S.; Tat, T.; Dozio, V.; Luong, N.; Imedio, E. Rodrigo
Safe stop IPI-NIVO trial: Early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab

SAFE STOP IPI-NIVO试验：在不可切除的III期或转移性黑色素瘤患者接受一线伊匹木单抗-纳武利尤单抗治疗后，若达到完全或部分缓解则早期停用纳武利尤单抗。

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Janssen, J. C.; van Dijk, B.; de Joode, K.; Aarts, M.; Van den Berkmortel, F.; Blank, C. U.; Boers-Sonderen, M.; Van den Eertwegh, F.; de Groot, J. W.; Jalving, M.; Joosse, A.; Huismans, A.; Kapiteijn, E.; Naipal, K. A. T.; Piersma, D.; Rikhof, B.; Vreugdenhil, G.; Westgeest, H. M.; Mulder, E. E. A. P.; van der Veldt, A. A. M.
B cells critical for outcome in high grade serous ovarian carcinoma

B细胞对高级别浆液性卵巢癌的预后至关重要

INTERNATIONAL JOURNAL OF CANCER
IF4.7
2024-08-220
OAAI
Vledder, Annege; Paijens, Sterre T.; Loiero, Dominik; Maagdenberg, Alexis; Duiker, Evelien W.; Bart, Joost; Hendriks, Anne M.; Jalving, Mathilde; Werner, Naomi; van Rooij, Nienke; Plat, Annechien; Wisman, G. Bea A.; Yigit, Refika; Roelofsen, Thijs; Kruse, Arnold J.; de Lange, Nastascha M.; Koelzer, Viktor H.; de Bruyn, Marco; Nijman, Hans W.

研究方向

暂未获取到该数据
E
Elisabeth G.E. de Vries
H 指数:121论文数:1,695被引数:6.7万
A
Adrienne H. Brouwers
H 指数:49论文数:390被引数:8,980
S
Steven de Jong
H 指数:59论文数:413被引数:1.2万
J
Jourik A. Gietema
H 指数:70论文数:486被引数:1.7万
R
Rudolf S.N. Fehrmann
H 指数:51论文数:240被引数:2.0万
A
Astrid A.M. van der Veldt
H 指数:44论文数:360被引数:6,873
G
Geke A.P. Hospers
H 指数:62论文数:565被引数:2.4万
S
Sjoukje F. Oosting
H 指数:43论文数:261被引数:9,731
C
Christian U. Blank
H 指数:95论文数:670被引数:5.8万
T
T. Jeroen N. Hiltermann
H 指数:36论文数:245被引数:7,813